Concern

There is a trend toward greater use of newer glucose-lowering drugs with cardiovascular benefit, raising hopes for better outcomes in patients with type 2 diabetes but with concern about the high cost of the agents, researchers say. Two new studies explore this relatively recent diabetes prescribing trend. In one study, […]